Su1930 – Safety and Efficacy of Olorinab, a Peripherally Restricted, Highly Selective, Cannabinoid Receptor 2 Agonist in a Phase 2A Study in Chronic Abdominal Pain Associated with Crohn’s Disease

Yacyshyn, Bruce, Ginsberg, Daniel C., Gilder, Kye · Gastroenterology · 2019